Vertex pharmaceuticals inc / ma (VRTX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09
Assets
Current assets:
Cash and cash equivalents

3,593

3,109

3,397

3,294

2,893

2,650

2,478

2,145

1,995

1,665

1,384

1,223

1,003

1,183

719

605

604

714

756

870

664

625

718

420

424

569

583

531

379

489

436

454

267

475

542

458

446

243

569

337

396

446

Marketable securities

596

698

598

656

584

518

577

622

481

423

427

445

405

250

408

465

421

327

249

145

516

761

759

798

900

895

839

899

860

831

861

769

712

493

116

135

376

788

633

641

696

838

Restricted cash and cash equivalents (VIE)

-

-

-

-

-

-

8

8

9

-

1

64

44

47

58

70

76

78

75

88

-

8

-

-

-

-

51

58

63

69

74

56

58

51

50

63

-

-

-

-

-

-

Accounts receivable, net

845

633

443

464

438

409

379

393

327

281

263

247

207

200

182

189

181

173

165

94

80

75

114

81

59

85

120

164

194

143

139

185

232

183

445

96

5

12

4

3

7

9

Inventory, Net

187

167

162

143

136

124

124

115

117

111

98

92

82

77

71

66

63

57

49

42

34

30

16

11

11

14

13

19

21

30

86

87

129

112

67

52

17

-

-

-

-

-

Prepaid expenses and other current assets

223

213

175

151

130

140

118

122

109

167

152

107

128

71

61

56

55

54

63

53

62

44

41

34

35

23

41

43

47

24

35

40

35

14

23

21

26

13

18

21

26

12

Total current assets

5,446

4,822

4,777

4,710

4,183

3,843

3,686

3,407

3,041

2,648

2,327

2,180

1,871

1,831

1,501

1,454

1,402

1,407

1,359

1,294

1,358

1,546

1,650

1,347

1,430

1,588

1,648

1,716

1,565

1,589

1,634

1,593

1,436

1,331

1,245

827

872

1,057

1,226

1,004

1,126

1,307

Property, Plant, And Equipment And Finance Lease Right-of-Use Asset, After Accumulated Depreciation And Amortization

736

745

733

731

742

812

808

815

800

789

759

740

708

698

687

690

690

697

706

713

708

715

720

730

726

696

648

581

504

433

124

272

170

133

101

84

70

72

65

60

58

62

Fan Pier buildings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

223

-

-

-

-

-

-

-

-

-

-

-

Goodwill

1,002

1,002

447

50

50

50

50

50

50

50

50

50

50

50

50

50

50

50

50

50

39

39

30

30

30

30

30

30

30

30

30

30

30

30

33

33

26

26

26

26

26

26

Intangible assets

400

400

-

-

-

0

29

29

29

29

29

284

284

284

284

284

284

284

284

284

29

29

-

-

-

0

250

250

250

663

663

663

663

663

663

769

518

518

518

518

518

518

Deferred tax assets

1,147

1,190

1,415

1,425

1,467

1,499

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease assets

-

-

60

58

60

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost method investments

-

-

-

-

-

-

-

-

-

-

20

20

20

20

53

33

30

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

30

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

22

22

22

22

22

22

0

0

0

0

-

0

0

31

31

32

34

34

34

34

34

34

34

34

34

30

30

Other assets

160

157

79

57

39

40

46

32

31

27

10

9

11

11

10

14

7

6

11

9

7

3

3

9

9

2

3

4

8

9

10

10

10

11

13

14

15

17

18

10

10

11

Total assets

8,893

8,318

7,514

7,033

6,543

6,245

4,620

4,335

3,952

3,546

3,198

3,285

2,946

2,896

2,609

2,548

2,487

2,498

2,433

2,374

2,165

2,334

2,406

2,117

2,197

2,319

2,582

2,584

2,392

2,759

2,718

2,604

2,345

2,204

2,091

1,763

1,538

1,725

1,888

1,654

1,770

1,955

Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable

100

87

92

77

82

110

92

83

74

73

77

75

63

61

50

51

75

74

78

72

43

71

38

55

49

49

51

48

59

101

83

59

73

74

49

67

34

35

24

46

29

36

Accrued expenses

1,258

1,116

1,173

1,069

532

958

504

479

411

443

378

345

277

315

292

275

272

305

249

206

176

209

244

237

234

271

280

260

274

264

273

271

241

243

229

141

116

134

127

106

92

118

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

6

-

6

3

6

3

0

-

-

0

Deferred revenues, current portion

-

-

-

-

-

-

-

-

-

-

13

7

6

6

9

11

14

16

14

14

15

17

21

27

28

21

31

32

35

27

27

27

30

45

55

65

74

74

98

78

69

74

Accrued restructuring expense, current portion

-

-

-

-

-

-

-

-

-

-

4

6

7

6

3

7

7

7

8

10

13

33

38

8

9

14

9

5

4

4

4

4

4

4

5

5

5

5

5

6

6

6

Capital lease obligations, current portion

-

-

-

-

-

-

11

15

16

22

19

18

19

19

17

17

17

15

14

13

19

17

18

19

18

16

14

10

8

13

-

-

-

0

-

-

-

-

-

-

-

-

Early access sales accrual

-

-

-

-

382

-

324

290

268

232

190

147

104

73

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Senior secured term loan, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

297

221

146

71

0

42

28

14

-

-

-

0

-

-

-

0

3

0

0

12

9

15

-

-

-

-

-

-

Credit facility

-

-

-

-

-

-

-

-

-

-

0

0

0

300

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible senior subordinated notes (due 2013), current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32

Secured notes (due 2012)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

98

94

92

136

45

45

-

-

Liability related to sale of milestone payments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

94

87

84

77

-

-

-

-

Other current liabilities

179

130

122

113

108

50

60

59

56

34

27

24

10

10

51

38

18

14

9

13

4

4

11

14

32

24

21

23

25

19

13

13

-

12

-

-

1

6

8

9

14

15

Total current liabilities

1,538

1,334

1,388

1,259

1,106

1,120

992

927

827

807

710

625

489

792

722

622

552

506

374

373

302

368

372

362

373

397

409

381

407

432

406

379

356

392

548

478

416

474

311

292

211

284

Long-term finance lease liabilities

532

538

541

551

560

581

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term operating lease liabilities

-

-

62

60

63

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues, excluding current portion

-

-

-

-

-

-

-

-

-

-

2

4

5

6

6

7

8

9

17

21

24

27

34

38

43

49

77

84

90

96

103

110

116

118

126

134

144

160

177

195

215

225

Accrued restructuring expense, excluding current portion

-

-

-

-

-

-

-

-

-

-

0

0

0

1

3

4

6

7

9

9

8

12

17

10

13

14

16

17

17

18

19

20

20

21

21

23

23

24

27

27

26

27

Capital lease obligations, excluding current portion

-

-

-

-

-

-

15

15

16

20

20

25

30

34

31

34

38

42

39

42

46

39

42

45

49

48

39

28

14

15

-

-

-

0

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

9

9

9

6

10

136

135

134

133

132

112

110

113

112

15

15

-

-

-

0

150

149

151

280

279

263

241

243

231

260

160

160

160

160

160

160

Convertible senior subordinated notes (due 2015)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

400

400

400

400

400

400

400

400

400

400

400

-

-

-

Secured notes (due 2012), excluding current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

87

86

125

121

Liability related to sale of potential future milestone payments, excluding current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

72

63

39

38

Construction financing lease obligation, excluding current portion

-

-

-

-

-

-

561

562

561

563

547

525

498

486

473

472

472

472

472

472

472

473

473

473

473

440

392

359

316

268

215

160

94

55

25

11

-

-

-

-

-

-

Long-term advance from collaborator

-

-

85

84

83

-

81

80

79

78

77

76

74

73

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Business Combination, Contingent Consideration, Liability, Noncurrent

178

176

175

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Senior secured term loan, excluding current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

74

149

223

294

251

266

280

294

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

181

183

7

8

5

108

26

25

27

27

26

25

28

28

30

30

31

31

34

41

32

21

15

15

12

11

10

16

16

13

28

28

10

7

7

6

2

2

2

1

0

0

Total liabilities

2,431

2,233

2,261

1,963

1,819

1,810

1,686

1,620

1,522

1,503

1,395

1,418

1,263

1,558

1,401

1,380

1,371

1,404

1,357

1,325

1,168

1,238

1,250

945

966

962

1,096

1,035

1,415

1,524

1,454

1,361

1,240

1,238

1,361

1,313

1,146

1,221

1,238

827

779

859

Commitments and contingencies

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

-

-

-

-

Redeemable noncontrolling interest (Alios)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39

39

38

38

38

37

37

37

36

36

-

-

-

-

-

-

Shareholders’ equity:
Preferred stock, $0.01 par value; 1,000 shares authorized; none issued and outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.01 par value; 500,000 shares authorized, 259,079 and 258,993 shares issued and outstanding, respectively

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

1

Additional paid-in capital

7,695

7,937

7,668

7,564

7,475

7,421

7,443

7,357

7,314

7,157

7,034

6,808

6,616

6,506

6,429

6,350

6,262

6,197

6,106

5,987

5,877

5,777

5,681

5,528

5,428

5,321

5,274

5,208

4,574

4,519

4,471

4,424

4,252

4,200

4,152

4,100

4,010

3,947

3,912

3,880

3,844

3,784

Accumulated other comprehensive income (loss)

13

-1

18

-3

6

0

0

-4

-39

-11

-25

-21

16

21

-3

-3

-4

1

1

-1

0

0

1

-0

-0

-0

-0

-1

-1

-0

-0

-0

-0

-1

-0

-0

-0

-1

-0

-0

-1

-0

Accumulated deficit

-1,250

-1,852

-2,436

-2,493

-2,761

-2,989

-4,540

-4,668

-4,876

-5,119

-5,220

-5,117

-5,135

-5,373

-5,406

-5,367

-5,303

-5,261

-5,188

-5,092

-4,904

-4,705

-4,528

-4,358

-4,199

-3,966

-4,011

-3,887

-3,829

-3,521

-3,445

-3,388

-3,323

-3,414

-3,573

-3,794

-3,620

-3,444

-3,264

-3,055

-2,855

-2,689

Total Vertex shareholders’ equity

-

-

-

-

-

-

2,906

2,686

2,401

2,028

1,791

1,671

1,500

1,156

1,021

981

957

939

922

894

976

1,075

1,155

1,172

1,230

1,356

1,264

1,322

746

999

1,027

1,037

930

786

579

307

-

503

-

-

-

-

Noncontrolling interest

-

-

-

-

-

-

28

28

29

13

12

195

182

181

186

187

159

153

154

153

21

21

-

-

-

0

182

186

191

196

198

167

137

141

114

105

-

-

-

-

-

-

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest

6,461

6,085

5,253

5,069

4,723

4,435

2,934

2,714

2,430

2,042

1,803

1,867

1,682

1,338

1,208

1,168

1,116

1,093

1,076

1,048

997

1,096

-

-

-

1,356

1,447

1,509

937

1,195

1,226

1,205

1,068

928

694

412

391

503

650

827

990

1,096

Total liabilities and shareholders’ equity

8,893

8,318

7,514

7,033

6,543

6,245

4,620

4,335

3,952

3,546

3,198

3,285

2,946

2,896

2,609

2,548

2,487

2,498

2,433

2,374

2,165

2,334

2,406

2,117

2,197

2,319

2,582

2,584

2,392

2,759

2,718

2,604

2,345

2,204

2,091

1,763

1,538

1,725

1,888

1,654

1,770

1,955